GMP IPO Watch
Nippon India BSE Sensex Next 30 ETF
Direct Plan · Nippon India Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +5.13% | +3.62% | 83 of 229 |
| 1M | +3.84% | +2.76% | 94 of 227 |
| 3M | -4.35% | -3.72% | 152 of 227 |
| 6M | -1.33% | -0.45% | 165 of 218 |
| YTD | +1.28% | -3.05% | 57 of 229 |
| 1Y | +3.27% | -0.32% | 33 of 193 |
| INCEPTION | +6.31% | — | — |
Ranked among: Exchange Traded Funds (ETFs) - Other ETF.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +1.69% | +12.52% | -8.82% | 75% | 30% |
| 6M | +3.81% | +13.57% | -6.77% | 84% | 35% |
| 1Y | +7.45% | +16.89% | -3.79% | 89% | 38% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity99.80%
- Debt0.00%
- Cash0.20%
- Other0.00%
Market Cap Split
- Large Cap86.88%
- Mid Cap12.92%
- Small Cap0.00%
- Others0.20%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 23.33 | — |
| P/B | 3.13 | — |
| Price / Sales | 1.95 | — |
| Price / Cash Flow | 16.03 | — |
| Dividend Yield (%) | 1.51 | — |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Shriram Finance | Finance | 5.46% | -1.63% |
| Hindalco Industries | Non - Ferrous Metals | 5.42% | -0.02% |
| JSW Steel | Ferrous Metals | 4.78% | +0.24% |
| Divis Laboratories | Pharmaceuticals & Biotechnology | 4.73% | +0.34% |
| Bajaj Auto | Automobiles | 4.61% | -0.18% |
| Grasim Industries | Cement & Cement Products | 4.59% | -0.03% |
| Coal India | Consumable Fuels | 4.08% | +0.67% |
| Eicher Motors | Automobiles | 3.92% | -0.15% |
| Adani Enterprises | Metals & Minerals Trading | 3.92% | +0.27% |
| TVS Motors | Automobiles | 3.82% | +0.07% |
| Nestle | Food Products | 3.74% | -0.17% |
| Oil & Natural Gas Corporation | Oil | 3.51% | +0.14% |
| Hindustan Aeronautics | Aerospace & Defense | 3.49% | +0.15% |
| Apollo Hospitals | Equity | 3.32% | -0.04% |
| SBI Life Insurance | Insurance | 3.05% | +0.12% |
View all 33 holdings
| Cipla | Pharmaceuticals & Biotechnology | 3.05% | +0.07% |
| Dr Reddys Laboratories | Pharmaceuticals & Biotechnology | 3.01% | +0.37% |
| Jio Financial Services | Finance | 2.86% | -0.13% |
| Cholamandalam Investment | Finance | 2.81% | -0.21% |
| Max Healthcare Institute | Equity | 2.75% | -0.05% |
| Hero Motocorp | Automobiles | 2.68% | +0.04% |
| Indian Hotels Company | Leisure Services | 2.57% | +0.21% |
| Tata Consumer Products | Agricultural Food & other Products | 2.45% | -0.04% |
| Tata Motors Passenger Vehicles | Automobiles | 2.39% | -0.08% |
| Tata Power | Power | 2.38% | +0.23% |
| Varun Beverages | Beverages | 2.33% | +0.28% |
| Britannia Industries | Food Products | 2.27% | -0.04% |
| HDFC Life Insurance | Insurance | 2.21% | +0.03% |
| Suzlon Energy | Electrical Equipment | 1.91% | -0.22% |
| Wipro | IT - Software | 1.69% | -0.23% |
| Triparty Repo | Reverse Repo / TREPS | 0.12% | — |
| Net Current Assets | Net Current Assets | 0.08% | — |
| Cash Margin - CCIL | Net Current Assets | 0.00% | — |
Sector Allocation · Sep 2026
View all 19 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 14.72 | 16.71 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.31 | -3.33 | Above Average |
| 3Y | -0.25 | -1.59 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.40 | 0.07 | Above Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Beta
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.98 | 1.00 | Good Risk Adjusted Returns |
What is this?
This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Motilal Oswal Nasdaq Q50 ETF | +33.42% | +31.36% | — | +12.73% |
| Tata Silver Exchange Traded Fund | +26.44% | — | — | +39.36% |
|
SBI Silver ETF
Regular Plan · Growth
|
+26.42% | — | — | +34.10% |
| Kotak Silver ETF | +26.35% | +36.48% | — | +28.03% |
| ICICI PRUDENTIAL SILVER ETF | +26.35% | +36.57% | — | +24.10% |
| Edelweiss Silver ETF | +26.32% | — | — | +35.41% |
| Motilal Oswal Silver ETF | +26.09% | — | — | +46.27% |
|
Nippon India Silver ETF
Direct Plan
|
+26.05% | +36.23% | — | +25.08% |
|
HDFC Silver ETF
Growth Option
|
+25.77% | +36.06% | — | +34.08% |
|
Nippon India Nifty Pharma ETF
Direct Plan
|
+22.83% | +22.93% | +15.06% | +13.35% |
More From Nippon Life India Asset Management Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Direct Plan · Growth Option
|
+61.78% | +49.40% | — | +24.96% |
|
Nippon India Silver ETF
Direct Plan
|
+26.05% | +36.23% | — | +25.08% |
|
Nippon India Silver ETF FOF
Direct Plan · IDCW Option
|
+24.99% | +35.38% | — | +24.09% |
|
Nippon India Nifty Pharma ETF
Direct Plan
|
+22.83% | +22.93% | +15.06% | +13.35% |
|
Nippon India Japan Equity Fund
Direct Plan · IDCW Option
|
+20.27% | +21.27% | +9.63% | +9.56% |
|
Nippon India ETF Gold BeES
Direct Plan
|
+16.58% | +30.82% | +23.10% | +15.30% |
|
Nippon India Gold Savings Fund
Direct Plan · Growth Option
|
+16.51% | +30.76% | +22.97% | +10.34% |
|
Nippon India US Equity Opportunities Fund
Direct Plan · IDCW Option
|
+11.90% | +18.73% | +10.93% | +14.93% |
|
Nippon India Pharma Fund
Direct Plan · Growth Option
|
+10.54% | +18.85% | +14.53% | +17.34% |
|
Nippon India Fixed Maturity Plan - XLV - Series 5
Direct Plan · Growth Option
|
+7.36% | +8.43% | — | +8.54% |
About This Scheme
Investment Objective
The investment objective of the scheme is to provide investment returns that commensurate to the total returns of the securities as represented by the BSE Sensex Next 30 Index before expenses, subject to tracking errors. However, there is no assurance that the investment objectiveof the Scheme will be achieved.
Stated Asset Allocation
Securities covered by the BSE Sensex Next 30 Index - 95% to 100%, Money Market Instruments - 0% to 5%. (with maturity not exceeding 91 days), including Tri-party repo on G-sec or T-bills, cash & cash equivalents.
Exit Load
Not Applicable
Fund Managers
Himanshu Mange
Primary
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.